127 related articles for article (PubMed ID: 2435334)
1. Preparation and disposition of asialofetuin-labelled liposome.
Tsuchiya S; Aramaki Y; Hara T; Hosoi K; Okada A
Biopharm Drug Dispos; 1986; 7(6):549-58. PubMed ID: 2435334
[TBL] [Abstract][Full Text] [Related]
2. Specific incorporation of asialofetuin-labeled liposomes into hepatocytes through the action of galactose-binding protein.
Hara T; Aramaki Y; Tsuchiya S; Hosoi K; Okada A
Biopharm Drug Dispos; 1987; 8(4):327-39. PubMed ID: 2441770
[TBL] [Abstract][Full Text] [Related]
3. Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes.
Hara T; Kuwasawa H; Aramaki Y; Takada S; Koike K; Ishidate K; Kato H; Tsuchiya S
Biochim Biophys Acta; 1996 Jan; 1278(1):51-8. PubMed ID: 8611607
[TBL] [Abstract][Full Text] [Related]
4. Selective incorporation of asialofetuin into hepatocyte of rat.
Aramaki Y; Inaba A; Tsuchiya S
Biopharm Drug Dispos; 1985; 6(4):389-400. PubMed ID: 2417637
[TBL] [Abstract][Full Text] [Related]
5. Preparation of asialofetuin-labeled liposomes with encapsulated human interferon-gamma and their uptake by isolated rat hepatocytes.
Ishihara H; Hara T; Aramaki Y; Tsuchiya S; Hosoi K
Pharm Res; 1990 May; 7(5):542-6. PubMed ID: 1694992
[TBL] [Abstract][Full Text] [Related]
6. Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents.
Wu J; Liu P; Zhu JL; Maddukuri S; Zern MA
Hepatology; 1998 Mar; 27(3):772-8. PubMed ID: 9500706
[TBL] [Abstract][Full Text] [Related]
7. Intracellular degradation of asialoglycoproteins in hepatocytes starts in a subgroup of lysosomes.
Berg T; Ford T; Kindberg G; Blomhoff R; Drevon C
Exp Cell Res; 1985 Feb; 156(2):570-4. PubMed ID: 2578406
[TBL] [Abstract][Full Text] [Related]
8. Proteins and peptides bound to long-circulating liposomes.
Maruyama K; Mori A; Bhadra S; Subbiah MT; Huang L
Biochim Biophys Acta; 1991 Nov; 1070(1):246-52. PubMed ID: 1721540
[TBL] [Abstract][Full Text] [Related]
9. Targeting of lactosylceramide-containing liposomes to hepatocytes in vivo.
Spanjer HH; Scherphof GL
Biochim Biophys Acta; 1983 Sep; 734(1):40-7. PubMed ID: 6193809
[TBL] [Abstract][Full Text] [Related]
10. Asialofetuin liposome-mediated human alpha1-antitrypsin gene transfer in vivo results in stationary long-term gene expression.
Dasí F; Benet M; Crespo J; Crespo A; Aliño SF
J Mol Med (Berl); 2001 May; 79(4):205-12. PubMed ID: 11409712
[TBL] [Abstract][Full Text] [Related]
11. Characterization, stability and in-vivo distribution of asialofetuin glycopeptide incorporating DSPC/CHOL liposomes prepared by mild cholate incubation.
Kallinteri P; Liao WY; Antimisiaris SG; Hwang KH
J Drug Target; 2001 Apr; 9(2):155-68. PubMed ID: 11697109
[TBL] [Abstract][Full Text] [Related]
12. Receptor-mediated transfer of pSV2CAT DNA to a human hepatoblastoma cell line HepG2 using asialofetuin-labeled cationic liposomes.
Hara T; Aramaki Y; Takada S; Koike K; Tsuchiya S
Gene; 1995 Jul; 159(2):167-74. PubMed ID: 7542617
[TBL] [Abstract][Full Text] [Related]
13. Receptor-mediated transfer of pSV2CAT DNA to mouse liver cells using asialofetuin-labeled liposomes.
Hara T; Aramaki Y; Takada S; Koike K; Tsuchiya S
Gene Ther; 1995 Dec; 2(10):784-8. PubMed ID: 8750019
[TBL] [Abstract][Full Text] [Related]
14. Evidence for in vivo hepatic uptake of a galactose-terminated glycoprotein in fish (Salmo alpinus L.).
Dannevig BH; Tolleshaug H; Berg T
Biochim Biophys Acta; 1981 Nov; 677(3-4):501-5. PubMed ID: 6170347
[TBL] [Abstract][Full Text] [Related]
15. Targeting of mitomycin C to the liver by the use of asialofetuin as a carrier.
Kaneo Y; Tanaka T; Iguchi S
Chem Pharm Bull (Tokyo); 1991 Apr; 39(4):999-1003. PubMed ID: 1716529
[TBL] [Abstract][Full Text] [Related]
16. Effects of lysosomal inhibitors on 125I-insulin and 125I-asialofetuin degradation by the isolated, perfused rat liver and isolated rat hepatocytes.
Ward WF; Moss AL
Diabetes; 1985 May; 34(5):446-51. PubMed ID: 2580748
[TBL] [Abstract][Full Text] [Related]
17. Multivalent interaction between asialofetuin and plasma membrane preparations from the rat liver.
Debanne MT; Regoeczi E; Hatton MW
Can J Biochem; 1980 Dec; 58(12):1414-20. PubMed ID: 6166359
[TBL] [Abstract][Full Text] [Related]
18. Monensin inhibits receptor-mediated endocytosis of asialoglycoproteins in rat hepatocytes.
Berg T; Blomhoff R; Naess L; Tolleshaug H; Drevon CA
Exp Cell Res; 1983 Oct; 148(2):319-30. PubMed ID: 6195005
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of asialoglycoproteins in cultured rat hepatocytes: evidence for receptor mediated uptake and degradation which is not feed-back regulated.
Drevon CA; Tolleshaug H; Carlander B; Berg T
Int J Biochem; 1983; 15(6):827-33. PubMed ID: 6190689
[TBL] [Abstract][Full Text] [Related]
20. Effect of leupeptin on the intracellular degradation of asialofetuin in isolated rat hepatocytes.
Berg T; Tolleshaug H
Acta Biol Med Ger; 1981; 40(10-11):1599-602. PubMed ID: 6177139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
